Article Text

Download PDFPDF

Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
  1. G Lennox,
  2. J Lowe,
  3. M Landon,
  4. E J Byrne,
  5. R J Mayer,
  6. R B Godwin-Austen
  1. Department of Neurology, Queen's Medical Centre, Nottingham, United Kingdom.


    Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities make a much less significant contribution. Cortical senile plaques also appear to be part of the pathology of diffuse Lewy body disease and should not therefore be used as an isolated diagnostic criterion for Alzheimer's disease. Diagnostic criteria for diffuse Lewy body disease are discussed.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.